POINT BIOPHARMA GLOBAL INC. Share-based Payment Arrangement, Expense
POINT BIOPHARMA GLOBAL INC. reported Share-based Payment Arrangement, Expense of $3.55 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-27.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2023-03-27
- POINT BIOPHARMA GLOBAL INC. share-based payment arrangement, expense for fiscal 2022 was $3.55M, a 53.98% increase from fiscal 2021.
- POINT BIOPHARMA GLOBAL INC. share-based payment arrangement, expense for fiscal 2021 was $2.30M, a 30.77% increase from fiscal 2020.
- POINT BIOPHARMA GLOBAL INC. share-based payment arrangement, expense for fiscal 2020 was $1.76M.
| Period end | Share-based Payment Arrangement, Expense 12 month |
|---|---|
| 2022-12-31 | $3.55M 10-K · filed 2023-03-27 |
| 2021-12-31 | $2.30M 10-K · filed 2023-03-27 |
| 2020-12-31 | $1.76M 10-K · filed 2022-03-25 |